The purpose of this study is to determine whether fosinopril and losartan are effective in the treatment of patients with Chronic Kidney Disease(CKD) stage 3.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
400
Fosinopril 10mg/day(oral) Losartan 50mg/day(oral)
Taizhou People's Hospital
Taizhou, Jiangsu, China
progress to End Stage Renal Disease
Time frame: within two years
double of serum creatinine
Time frame: within two years
all cause mortality
Time frame: within two years
decreased proteinuria
Time frame: within two years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The 1st Affiliated Hospital of College of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Guangxing Hospital
Hangzhou, Zhejiang, China
Shaoyifu Hospital
Hangzhou, Zhejiang, China
Ningbo Lihuili Hospital
Ningbo, Zhejiang, China
Wenling 1st People's Hospital
Wenling, Zhejiang, China
The First affiliated Hospital of Wenzhou Medical College
Wenzhou, Zhejiang, China
Xiangshan People's Hospital
Xiangshan, Zhejiang, China
Renji Hospital
Shanghai, China
Changzheng Hospital
Shanghai, China
...and 16 more locations